ACE and congestive heart failure: Although most patients with systolic dysfunction of the SRV receive conventional pharmacotherapy for CHF, it should be noted that in this population beta-blockers, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers showed mixed results (23-27).